Todays CallAnyone listen?
Did you catch Adams first ever definitively clear pivot away from biosynthesis?
Yep, he wants to be like GWPharma and focus on the pharmaceutical drug approach now.
Of course he does! This gets attention off of Integrasyn - which as I predicted - is no where near commercialization (as we have previously been told).
Who enters into a collaboration with another company and has no preset timelines? When asked about the Baymedica timeline, Adams stated "we don't have a specific timeline.
I would suppose that'll take place over the first half of this year. Maybe sometime around mid year we'll be able to report back with the findings."
"I would suppose?" hahaha
This is why they rushed to do the private cash raise - they have now made it clear to us that there is absolutely no catalyst, in the near or mid term, to drive sp appreciation.....
#timetoreplaceadams